Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Optimization and Simulation of Orthopedic Spine Surgery Cases at Mayo Clinic
Ozen, Asli, Marmor, Yariv N. , Rohleder, Thomas R., Balasubramanian, Hari , Huddleston, Jeanne M. , Huddleston, P.M. , Huddleston, Paul M

Manufacturing & Service Operations Management | November 20, 2015 | Volume: 18 | Issue: 1 | Pages: 157-175

10.1287/msom.2015.0564 Get It

Spine surgeries tend to be lengthy (mean time of 4 hours) and highly variable (with some surgeries lasting 18 hours or more). This variability along with patient preferences driving scheduling decisions resulted in both low operating room (OR) utilization and significant overtime for surgical teams at Mayo Clinic. In this paper we discuss the development of an improved scheduling approach for spine surgeries over a rolling planning horizon. First, data mining and statistical analysis was performed using a large data set to identify categories of surgeries that could be grouped together based on surgical time distributions and could be categorized at the time of case scheduling. These surgical categories are then used in a hierarchical optimization approach with the objective of maximizing a weighted combination of OR utilization and net profit. The optimization model is explored to consider trade-offs and relationships among utilization levels, financial performance, overtime allowance, and case mix. The new scheduling approach was implemented via a custom Web-based application that allowed the surgeons and schedulers to interactively identify best surgical days with patients. A pilot implementation resulted in a utilization increase of 19% and a reduction in overtime by 10%.
Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis
Tefferi, Ayalew , Cerquozzi, Sonia , Liaw, Jenny

American Journal of Hematology | November 20, 2015 | Volume: 91 | Issue: 2 | Pages: No page available

10.1002/ajh.24248 | PMID 26587685 Get It

Is Monitoring of Total Beam-On Time a Sufficient Measure of Patient Radiation Exposure in the Interventional Cardiology Laboratories?
Fetterly, Kenneth A.

American Journal of Roentgenology | November 20, 2015 | Volume: 205 | Issue: 6 | Pages: W567-W567

10.2214/ajr.15.14991 | PMID 26587945 Get It

Characterization of Urinary Stone Composition by Use of Third-Generation Dual-Source Dual-Energy CT With Increased Spectral Separation
Duan, Xinhui , Li, Zhoubo , Yu, Lifeng , Halaweish, Ahmed F., Yu, Lifeng , Leng, Shuai , Fletcher, Joel G. , McCollough, Cynthia H.

American Journal of Roentgenology | November 20, 2015 | Volume: 205 | Issue: 6 | Pages: 1203-1207

10.2214/ajr.15.14348 | PMID 26587926 Get It

Small (< 4 cm) Renal Masses: Differentiation of Angiomyolipoma Without Visible Fat From Renal Cell Carcinoma Using Unenhanced and Contrast-Enhanced CT
Takahashi, Naoki , Kitajima, Kazuhiro , Gomez‐Cardona, Daniel, Thapa, Prabin , Carter, Rickey E. , Leibovich, Bradley C. , Sasiwimonphan, Kewalee , Sasaguri, Kohei, Gomez-Cardona, Daniel, Leng, Shuai , Kawashima, Akira , Carter, Rickey E , Takahashi, Naoki

American Journal of Roentgenology | November 20, 2015 | Volume: 205 | Issue: 6 | Pages: 1194-1202

10.2214/ajr.14.14183 | PMID 26587925 Get It

Diagnosis of Usual Interstitial Pneumonitis in the Absence of Honeycombing: Evaluation of Specific CT Criteria With Clinical Follow-Up in 38 Patients
Gruden, James F. , Panse, Prasad M., Jensen, Eric A., Wellnitz, Clinton V., Wesselius, Lewis , Gotway, Michael B.

American Journal of Roentgenology | November 20, 2015 | Volume: 206 | Issue: 3 | Pages: 472-480

10.2214/ajr.15.14525 | PMID 26587800 Get It

Dural arteriovenous fistula-induced thalamic dementia: report of 4 cases
Holekamp, Terrence F., Mollman, Matthew E., Murphy, Rory K. J. , Kolar, Grant R. , Kramer, Neha M. , Derdeyn, Colin P. , Moran, Christopher J. , Perrin, Richard J. , Rich, Keith M. , Zipfel, Gregory J. , Lanzino, Giuseppe , Derdeyn, Colin P

Journal of Neurosurgery | November 20, 2015 | Volume: 124 | Issue: 6 | Pages: 1752-1765

10.3171/2015.5.jns15473 | PMID 26587655 Get It

Nonhemorrhagic neurological deficits are underrecognized symptoms of intracranial dural arteriovenous fistulas (dAVFs) having cortical venous drainage. These symptoms are the consequence of cortical venous hypertension and portend a clinical course with increased risk of neurological morbidity and mortality. One rarely documented and easily misinterpreted type of nonhemorrhagic neurological deficit is progressive dementia, which can result from venous hypertension in the cortex or in bilateral thalami. The latter, which is due to dAVF drainage into the deep venous system, is the less common of these 2 dementia syndromes. Herein, the authors report 4 cases of dAVF with venous drainage into the vein of Galen causing bithalamic edema and rapidly progressive dementia. Two patients were treated successfully with endovascular embolization, and the other 2 patients were treated successfully with endovascular embolization followed by surgery. The radiographic abnormalities and presenting symptoms rapidly resolved after dAVF obliteration in all 4 cases. Detailed descriptions of these 4 cases are presented along with a critical review of 15 previously reported cases. In our analysis of these 19 published cases, the following were emphasized: 1) the clinical and radiographic differences between dAVF-induced thalamic versus cortical dementia syndromes; 2) the differential diagnosis and necessary radiographic workup for patients presenting with a rapidly progressive thalamic dementia syndrome; 3) the frequency at which delays in diagnosis occurred and potentially dangerous and avoidable diagnostic procedures were used; and 4) the rapidity and completeness of symptom resolution following dAVF treatment.
Interventions for dissociated vertical deviation
Wang, Xue , Holmes, Jonathan M. , Hatt, Sarah R. , Holmes, Jonathan M.

Cochrane Database of Systematic Reviews | November 20, 2015 | Volume: 2016 | Issue: 1 | Pages: No page available

10.1002/14651858.cd010868.pub2 | PMID 26587695 Get It

Abstract A1-64: Molecular and clinical characterization of 1,577 primary prostate cancer tumors reveals novel clinical and biological insights into its subtypes
Alshalalfa, Mohammed , Tomlins, Scott A. , Erho, Nicholas , Yousefi, Kasra, Zhao, Shuang G. , Dicker, Adam P. , Ross, Ashley E. , Karnes, Jeffery, Jenkins, Robert B. , Feng, Felix Y. , Zhao, Shuang G , Den, Robert B. , Trock, Bruce J , Marzo, Angelo M. De , Schaeffer, Edward M. , Klein, Eric A. , Magi‐Galluzzi, Cristina , Davicioni, Elai , Dicker, Adam P

Cancer Research | November 20, 2015 | Volume: 75 | Issue: 22_Supplement_1 | Pages: A1-64-A1-64

10.1158/1538-7445.transcagen-a1-64 Get It

Abstract Background: Prostate cancer molecular subtypes based on ETS gene fusions and SPINK1 were originally identified through distinct gene expression profiles. Such molecular subtypes may have utility in disease stratification and clonality assessment, complementing available purely prognostic tests. Hence, we determined the analytical validity of molecular subtyping and explored clinical associations using global gene expression profiles in a large cohort of PCa. Methods: We analyzed 1,577 patient Affymetrix Human Exon 1.0ST GeneChip expression profiles from 8 radical prostatectomy (RP) cohorts; 5 of them generated as part of the Decipher® platform for the Decipher® discovery or validation. Multi-feature random forest classifiers and outlier analysis were used to define microarray-based molecular subtypes and characterize clinical associations. Results: A random forest (RF) classifier (m-ERG) was trained and validated to predict ERG fusion status using separate subsets of a single-institution RP cohort (total n=407) with known ERG rearrangement status defined by FISH, achieving &gt;95% sensitivity and specificity in the validation subset. The model was then applied to 7 independent RP cohorts to predict ERG rearrangement status. Less frequent rearrangements involving other ETS genes (ETV1, ETV4, ETV5, FLI1) or SPINK1 over-expression were predicted based on gene expression outlier analysis. Across cohorts, 45%, 9% 8% and 38% of PCa were classified as ERG+, ERG—ETS+, ERG—SPINK+, and Triple Negative (ERG—/ETS—/SPINK1—), respectively. Global gene expression analysis shows that the four subtypes could be collapsed into three entities (ERG+, ERG—ETS+ and SPINK+/Triple Negative) based on expression patterns and clinical characteristics similarity. Based on multivariable analysis, ERG+ is significantly associated with lower pre-PSA (p&lt;0.001), lower Gleason score (p&lt;0.001), the presence of extraprostatic extension (p&lt;0.001) and European Americans (p&lt;0.001), but not associated with outcome. ERG—ETS+ is significantly associated with SVI (p=0.01) and ERG—SPINK+ is enriched in African Americans (p&lt;0.001). Conclusions: The Decipher® platform can accurately determine ERG rearrangement status and PCa molecular subtypes. Inclusion of molecular subtyping, such as m-ERG status, may enable additional precision medicine opportunities in prognostic tests and provides insights into the development of novel therapeutic approaches. Citation Format: Mohammed Alshalalfa, Scott A. Tomlins, Nicholas Erho, Kasra Yousefi, Shuang Zhao, Robert B. Den, Adam P. Dicker, Bruce Trock, Angelo DeMarzo, Edward M. Schaeffer, Ashley Ross, Eric A. Klein, Cristina Magi-Galluzzi, Jeffery R. Karnes, Robert B Jenkins, Elai Davicioni, Felix Feng. Molecular and clinical characterization of 1,577 primary prostate cancer tumors reveals novel clinical and biological insights into its subtypes. [abstract]. In: Proceedings of the AACR Special Conference on Translation of the Cancer Genome; Feb 7-9, 2015; San Francisco, CA. Philadelphia (PA): AACR; Cancer Res 2015;75(22 Suppl 1):Abstract nr A1-64.
Abstract A1-09: Functional analysis of the chr13q22.1 pancreatic cancer risk locus suggests allele-specific effects on DIS3 expression with prognostic implications
Ibrahim, Abdisamad , Emmanuel, Mickey , Manmiller, Sarah, Jia, Jinping , Collins, Irene , Ylaya, Kris , Altekruse, Sean F. , Petersen, Gloria M. , Ámundadóttir, Laufey T. , Hoskins, Jason W. , Jia, Jinping, Parikh, Hemang M. , Hewitt, Stephen M. , Amundadottir, Laufey

Cancer Research | November 20, 2015 | Volume: 75 | Issue: 22_Supplement_1 | Pages: A1-09-A1-09

10.1158/1538-7445.transcagen-a1-09 Get It

Abstract A genome-wide association study (GWAS) of pancreatic cancer conducted within the NCI Cohort Consortium (PanScan I and II) identified pancreatic cancer susceptibility loci on chromosomes 1q32.1/NR5A2, 5p15.33/CLPTM1L/TERT, 9q34.2/ABO, and 13q22.1. The most significant single-nucleotide polymorphism (SNP) identified on 13q22.1, rs9543325, lies in a ~600 kb gene desert; the nearest genes are KLF5, KLF12, PIBF1, DIS3, and BORA (265–586 kb away). Imputation using the 1000 Genomes and DCEG reference datasets did not improve the GWAS signal, but produced a set of highly correlated SNPs for functional follow-up. We performed eQTL analysis to test for association between the genotypes of these functional candidate variants and expression of nearby genes. Among 64 normal derived pancreatic tissue samples, DIS3 expression showed the strongest association with a 30 bp indel variant in the risk locus (P = 4.8 × 10-4), indicating risk alleles associate with reduced DIS3 expression. Mutations in DIS3 have previously been identified in acute myeloid leukemia and multiple myeloma, and its expression has been correlated with metastatic potential in colorectal cancer, suggesting DIS3 is relevant to cancer biology. Chromosome conformation capture identified a physical interaction between the indel-containing locus and a region near the DIS3 promoter. Luciferase assay for regulatory function of this indel-containing locus revealed allele-specific silencer activity for the insertion allele. Supershift electromobility shift assay (EMSA) demonstrated binding of LEF1 specifically to the insertion allele of the indel, which contains two in silico predicted LEF1 binding elements. Finally, through immunohistochemical analysis, high DIS3 protein levels associated with better survival for pancreatic cancer patients (hazard ratio = 2.87, 95% CI = 1.49–5.53, P = 0.001). Our results suggest that at least one target gene for the pancreatic cancer risk variants on chr13q22.1 may be DIS3, and that the underlying biology may be mediated by the novel indel through a long-range repressive effect on DIS3 expression. Citation Format: Jason W. Hoskins, Abdisamad Ibrahim, Mickey Emmanuel, Sarah Manmiller, Jinping Jia, Hemang Parikh, Irene Collins, Kris Ylaya, Sean F. Altekruse, Stephen M. Hewitt, Gloria M. Petersen, Laufey T. Amundadottir. Functional analysis of the chr13q22.1 pancreatic cancer risk locus suggests allele-specific effects on DIS3 expression with prognostic implications. [abstract]. In: Proceedings of the AACR Special Conference on Translation of the Cancer Genome; Feb 7-9, 2015; San Francisco, CA. Philadelphia (PA): AACR; Cancer Res 2015;75(22 Suppl 1):Abstract nr A1-09.